Leschův-Nyhanův syndrom [Lesch-Nyhan Syndrome]

tematický
20
Termíny

deficit hypoxantin-guaninfosforibozyltransferázy
deficit hypoxantinfosforibozyltransferázy
kompletní deficit HPRT
kompletní deficit hypoxanthin-fosforibosyltransferázy

 

Choreoathetosis Self-Mutilation Hyperuricemia Syndrome
Choreoathetosis Self-Mutilation Syndrome
Complete HGPRT Deficiency Disease
Complete HPRT Deficiency
Complete Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency
Deficiency Disease, Complete HGPRT
Deficiency Disease, Hypoxanthine-Phosphoribosyl-Transferase
Deficiency of Guanine Phosphoribosyltransferase
Deficiency of Hypoxanthine Phosphoribosyltransferase
HGPRT Deficiency
HGPRT Deficiency Disease, Complete
Hypoxanthine Guanine Phosphoribosyltransferase 1 Deficiency
Hypoxanthine Guanine Phosphoribosyltransferase Deficiency
Hypoxanthine Phosphoribosyltransferase Deficiency
Hypoxanthine-Phosphoribosyl-Transferase Deficiency Disease
Juvenile Gout, Choreoathetosis, Mental Retardation Syndrome
Juvenile Hyperuricemia Syndrome
Lesch-Nyhan Disease
Primary Hyperuricemia Syndrome
Total HPRT Deficiency
Total Hypoxanthine-Guanine Phosphoribosyl Transferase Deficiency
X-Linked Hyperuricemia
X-Linked Primary Hyperuricemia

Perzistentní odkaz   https://www.medvik.cz/link/D007926
Definice

Soubor příznaků vrozené metabolické poruchy purinů (absence hypoxanthinguaninfosforibosyltransferázy). Dědičnost je vázána na X chromozom. Chybí konverze hypoxanthinu a xanthinu na nukleotidy, důsledkem je akumulace fosforibosylpyrofosfátů v buňkách, která stimuluje produkci purinů de novo. Vada se manifestuje v kojeneckém věku opožděným motorickým vývojem, po 1. roce se rozvíjí neurologická symptomatologie (choreoatetóza, spasticita končetin, klonus kotníků) a výrazné poruchy chování (sebedestruktivní tendence, sebepoškozování). Hladina močové kyseliny je výrazně zvýšená. (upraveno podle: Velký lékařský slovník online, 2018 http://lekarske.slovniky.cz)

An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. (Menkes, Textbook of Child Neurology, 5th ed, pp127)

DUI
D007926 MeSH Prohlížeč
CUI
M0012368
Předchozí užití
Athetosis (1966-1970); Mental Retardation (1966-1970); Purine-Pyrimidine Metabolism, Inborn Errors (1966-1970); Self Mutilation (1966-1970)
Historická pozn.
1973(1971)
Veřejná pozn.
1973

C Nemoci
C10.228.140 nemoci mozku 1 183
C10.228.140.163 metabolické nemoci mozku 85
C10.228.140.163.100.084 adrenoleukodystrofie 43
C10.228.140.163.100.320 galaktosemie 44
C10.228.140.163.100.355 Hartnupova nemoc 2
C10.228.140.163.100.360 hepatolentikulární degenerace 243
C10.228.140.163.100.362 dědičné demyelinizační nemoci CNS 12
C10.228.140.163.100.365 homocystinurie 108
C10.228.140.163.100.375 neketotická hyperglycinemie 7
C10.228.140.163.100.380 hyperlysinemie
C10.228.140.163.100.412 Leighova nemoc 26
C10.228.140.163.100.425 Leschův-Nyhanův syndrom 20
C10.228.140.163.100.520 nemoc s močí javorového sirupu 8
C10.228.140.163.100.535 syndrom MELAS 17
C10.228.140.163.100.540 Menkesova choroba 12
C10.228.140.163.100.545 syndrom MERRF 4
C10.228.140.163.100.593 nedostatek mevalonátkinázy 16
C10.228.140.163.100.640 okulocerebrorenální syndrom 9
C10.228.140.163.100.687 fenylketonurie 286
C10.228.140.163.100.725 nedostatek pyruvátkarboxylázy
C10.228.140.163.100.813 Refsumova nemoc 6
C10.228.140.163.100.844 Refsumova nemoc infantilní
C10.228.140.163.100.875 tyrosinemie 18
C10.228.140.163.100.937 vrozené poruchy cyklu močoviny 7
C10.228.140.163.100.968 Zellwegerův syndrom 10
C10.597.606.360 mentální retardace 1 048
C10.597.606.360.455.124 adrenoleukodystrofie 43
C10.597.606.360.455.249 Coffinův-Lowryho syndrom
C10.597.606.360.455.500 syndrom fragilního X 63
C10.597.606.360.455.562 glykogenóza typu IIb 11
C10.597.606.360.455.625 Leschův-Nyhanův syndrom 20
C10.597.606.360.455.687 Menkesova choroba 12
C10.597.606.360.455.750 mukopolysacharidóza II 25
C10.597.606.360.455.937 Rettův syndrom 53
C16.320.322.500.124 adrenoleukodystrofie 43
C16.320.322.500.249 Coffinův-Lowryho syndrom
C16.320.322.500.500 syndrom fragilního X 63
C16.320.322.500.625 Leschův-Nyhanův syndrom 20
C16.320.322.500.687 Menkesova choroba 12
C16.320.322.500.750 mukopolysacharidóza II 25
C16.320.322.500.937 Rettův syndrom 53
C16.320.400.525.124 adrenoleukodystrofie 43
C16.320.400.525.249 Coffinův-Lowryho syndrom
C16.320.400.525.500 syndrom fragilního X 63
C16.320.400.525.625 Leschův-Nyhanův syndrom 20
C16.320.400.525.687 Menkesova choroba 12
C16.320.400.525.750 mukopolysacharidóza II 25
C16.320.400.525.937 Rettův syndrom 53
C16.320.565.189.084 adrenoleukodystrofie 43
C16.320.565.189.320 galaktosemie 44
C16.320.565.189.355 Hartnupova nemoc 2
C16.320.565.189.360 hepatolentikulární degenerace 243
C16.320.565.189.365 homocystinurie 108
C16.320.565.189.375 neketotická hyperglycinemie 7
C16.320.565.189.380 hyperlysinemie
C16.320.565.189.412 Leighova nemoc 26
C16.320.565.189.425 Leschův-Nyhanův syndrom 20
C16.320.565.189.535 syndrom MELAS 17
C16.320.565.189.540 Menkesova choroba 12
C16.320.565.189.545 syndrom MERRF 4
C16.320.565.189.593 nedostatek mevalonátkinázy 16
C16.320.565.189.640 okulocerebrorenální syndrom 9
C16.320.565.189.687 fenylketonurie 286
C16.320.565.189.813 Refsumova nemoc 6
C16.320.565.189.844 Refsumova nemoc infantilní
C16.320.565.189.875 tyrosinemie 18
C16.320.565.189.968 Zellwegerův syndrom 10
C16.320.565.798.368 dna (nemoc) 373
C16.320.565.798.594 Leschův-Nyhanův syndrom 20
C18.452 metabolické nemoci 1 200
C18.452.132.100.084 adrenoleukodystrofie 43
C18.452.132.100.320 galaktosemie 44
C18.452.132.100.355 Hartnupova nemoc 2
C18.452.132.100.360 hepatolentikulární degenerace 243
C18.452.132.100.365 homocystinurie 108
C18.452.132.100.375 neketotická hyperglycinemie 7
C18.452.132.100.380 hyperlysinemie
C18.452.132.100.412 Leighova nemoc 26
C18.452.132.100.425 Leschův-Nyhanův syndrom 20
C18.452.132.100.535 syndrom MELAS 17
C18.452.132.100.540 Menkesova choroba 12
C18.452.132.100.545 syndrom MERRF 4
C18.452.132.100.593 nedostatek mevalonátkinázy 16
C18.452.132.100.640 okulocerebrorenální syndrom 9
C18.452.132.100.687 fenylketonurie 286
C18.452.132.100.813 Refsumova nemoc 6
C18.452.132.100.844 Refsumova nemoc infantilní
C18.452.132.100.875 tyrosinemie 18
C18.452.132.100.968 Zellwegerův syndrom 10
C18.452.648.189.084 adrenoleukodystrofie 43
C18.452.648.189.320 galaktosemie 44
C18.452.648.189.355 Hartnupova nemoc 2
C18.452.648.189.360 hepatolentikulární degenerace 243
C18.452.648.189.365 homocystinurie 108
C18.452.648.189.375 neketotická hyperglycinemie 7
C18.452.648.189.380 hyperlysinemie
C18.452.648.189.412 Leighova nemoc 26
C18.452.648.189.425 Leschův-Nyhanův syndrom 20
C18.452.648.189.535 syndrom MELAS 17
C18.452.648.189.540 Menkesova choroba 12
C18.452.648.189.545 syndrom MERRF 4
C18.452.648.189.593 nedostatek mevalonátkinázy 16
C18.452.648.189.640 okulocerebrorenální syndrom 9
C18.452.648.189.687 fenylketonurie 286
C18.452.648.189.813 Refsumova nemoc 6
C18.452.648.189.844 Refsumova nemoc infantilní
C18.452.648.189.875 tyrosinemie 18
C18.452.648.189.968 Zellwegerův syndrom 10
C18.452.648.798.368 dna (nemoc) 373
C18.452.648.798.594 Leschův-Nyhanův syndrom 20

Lesch-Nyhan Syndrome, Neurologic Variant Disease MeSH Prohlížeč